| NOVARTIS N | 82.00 / +0.12% |
News
- Novartis Agrees to Pay $678 Million to Settle Allegations of Illegal Kickbacks Involving Several of the Company's Cardiovascular Drugs
07/02/2020 / 02:28 - GlobeNewswire - SEC Charges Novartis AG with FCPA Violations
06/25/2020 / 18:51 - Newsfile Corp - Novartis' net sales jump 11% to $12.28B in Q1
04/28/2020 / 07:05 - TeleTrader - US accepts 30M doses of hydroxychloroquine by Novartis
03/30/2020 / 01:53 - TeleTrader - Novartis CEO: Too soon to say if malaria drug helps COVID-19
03/27/2020 / 11:40 - TeleTrader - Novartis to donate 130M doses of hydroxychloroquine
03/20/2020 / 17:15 - TeleTrader - Novartis Q4 EPS down to $0.5
01/29/2020 / 07:07 - TeleTrader - Novartis nears deal to acquire Medicines - report
11/23/2019 / 20:54 - TeleTrader - Novartis' net sales up 10% to $12.17B in Q3
10/22/2019 / 07:03 - TeleTrader - ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/25/2019 / 17:20 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/23/2019 / 16:23 - GlobeNewswire - ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09/18/2019 / 17:40 - GlobeNewswire - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Novartis AG
09/13/2019 / 16:15 - GlobeNewswire - Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS)
09/11/2019 / 22:30 - GlobeNewswire - INVESTOR ALERT: Law Offices of Howard G. Smith Continues its Investigation on Behalf of Novartis AG Investors (NVS)
09/11/2019 / 19:44 - GlobeNewswire
Real-time